WHO ICTRP trial
Effects of Mediterranean Diet and naltrexone/bupropion treatment in overweight…
KCT0003142 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0003142 |
|---|---|
| Public title | Effects of Mediterranean Diet and naltrexone/bupropion treatment in overweight and obese breast cancer patients |
| Scientific title | The effects of Mediterranean Diet and naltrexone/bupropion treatment on inflammation and metabolic risk factor of overweight breast cancer patients after breast cancer treatment |
| Primary sponsor | Yonsei University Health System, Gangnam Severance Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Endocrine, nutritional and metabolic disease |
| Interventions | Drug, Behavioral : 1) Drug: naltrexone/bupropion Naltrexone hydrochloride (HCl) 8 mg/Bupropion hydrochloride (HCl) 90 mg extended release (ER) combination tablets, orally, one tablet, in the morning, daily, for 1 week, followed by… |
| Registration date | Aug 29, 2018 |
| Target size | 90 |
| Secondary IDs | NCT03581630 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: